内分泌系薬の世界市場レポート2020

• 英文タイトル：Global Endocrine System Drugs Sales Market Report 2020

• レポートコード：20QY06-07947 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、内分泌系薬のグローバル市場について種類別（糖尿病薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他）、用途別（病院、診療所、医療センター、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・内分泌系薬市場の概要 ・世界の主要地域別内分泌系薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の内分泌系薬市場規模2015-2026：種類別（糖尿病薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他） ・世界の内分泌系薬市場規模2015-2026：用途別（病院、診療所、医療センター、その他） ・内分泌系薬の北米市場規模2015-2020 ・内分泌系薬のヨーロッパ市場規模2015-2020 ・内分泌系薬の中国市場規模2015-2020 ・内分泌系薬の日本市場規模2015-2020 ・内分泌系薬の東南アジア市場規模2015-2020 ・内分泌系薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Sanofi、Merck、Eli Lilly、AstraZeneca、AbbVie） ・内分泌系薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・内分泌系薬の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Endocrine System Drugs Market
The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Endocrine System Drugs Scope and Market Size
The global Endocrine System Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endocrine System Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Endocrine System Drugs market is segmented into
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Other

Segment by Application, the Endocrine System Drugs market is segmented into
Hospitals
Clinics
Medical Center
Other
The Endocrine System Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Endocrine System Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Endocrine System Drugs Market Share Analysis
Endocrine System Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Endocrine System Drugs business, the date to enter into the Endocrine System Drugs market, Endocrine System Drugs product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
…

レポート目次

---

Table of Contents

1 Endocrine System Drugs Market Overview
1.1 Endocrine System Drugs Product Scope
1.2 Endocrine System Drugs Segment by Type
1.2.1 Global Endocrine System Drugs Sales by Type (2020-2026)
1.2.2 Diabetes Drug
1.2.3 Human Growth Hormones
1.2.4 Thyroid Hormone Disorder Drugs
1.2.5 Other
1.3 Endocrine System Drugs Segment by Application
1.3.1 Global Endocrine System Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Medical Center
1.3.5 Other
1.4 Endocrine System Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Endocrine System Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Endocrine System Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Endocrine System Drugs Price Trends (2015-2026)

2 Endocrine System Drugs Estimate and Forecast by Region
2.1 Global Endocrine System Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Endocrine System Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Endocrine System Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Endocrine System Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Endocrine System Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Endocrine System Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Endocrine System Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Endocrine System Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Endocrine System Drugs Estimates and Projections (2015-2026)
2.4.3 China Endocrine System Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Endocrine System Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Endocrine System Drugs Estimates and Projections (2015-2026)
2.4.6 India Endocrine System Drugs Estimates and Projections (2015-2026)
3 Global Endocrine System Drugs Competition Landscape by Players
3.1 Global Top Endocrine System Drugs Players by Sales (2015-2020)
3.2 Global Top Endocrine System Drugs Players by Revenue (2015-2020)
3.3 Global Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine System Drugs as of 2019)
3.4 Global Endocrine System Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Endocrine System Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Endocrine System Drugs Players (Opinion Leaders)
4 Global Endocrine System Drugs Market Size by Type
4.1 Global Endocrine System Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Endocrine System Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Endocrine System Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Endocrine System Drugs Price by Type (2014-2020)
4.2 Global Endocrine System Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Endocrine System Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Endocrine System Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Endocrine System Drugs Price Forecast by Type (2021-2026)
5 Global Endocrine System Drugs Market Size by Application
5.1 Global Endocrine System Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Endocrine System Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Endocrine System Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Endocrine System Drugs Price by Application (2015-2020)
5.2 Global Endocrine System Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Endocrine System Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Endocrine System Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Endocrine System Drugs Price Forecast by Application (2021-2026)

3 North America Endocrine System Drugs Market Facts & Figures
3.2 North America Endocrine System Drugs Sales Market Share by Company (2015-2020)
3.3 North America Endocrine System Drugs Sales Market Share by Type (2015-2020)
3.4 North America Endocrine System Drugs Sales Market Share by Application (2015-2020)

4 Europe Endocrine System Drugs Market Facts & Figures
4.2 Europe Endocrine System Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Endocrine System Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Endocrine System Drugs Sales Market Share by Application (2015-2020)

5 China Endocrine System Drugs Market Facts & Figures
5.2 China Endocrine System Drugs Sales Market Share by Company (2015-2020)
5.3 China Endocrine System Drugs Sales Market Share by Type (2015-2020)
5.4 China Endocrine System Drugs Sales Market Share by Application (2015-2020)

6 Japan Endocrine System Drugs Market Facts & Figures
6.2 Japan Endocrine System Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Endocrine System Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Endocrine System Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Endocrine System Drugs Market Facts & Figures
7.2 Southeast Asia Endocrine System Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Endocrine System Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Endocrine System Drugs Sales Market Share by Application (2015-2020)

8 India Endocrine System Drugs Market Facts & Figures
8.2 India Endocrine System Drugs Sales Market Share by Company (2015-2020)
8.3 India Endocrine System Drugs Sales Market Share by Type (2015-2020)
8.4 India Endocrine System Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Endocrine System Drugs Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Endocrine System Drugs Corporation Information
12.1.2 Novo Nordisk Endocrine System Drugs Business Overview and Total Revenue
12.1.3 Novo Nordisk Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Endocrine System Drugs Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi
12.2.1 Sanofi Endocrine System Drugs Corporation Information
12.2.2 Sanofi Endocrine System Drugs Business Overview and Total Revenue
12.2.3 Sanofi Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Endocrine System Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Endocrine System Drugs Corporation Information
12.3.2 Merck Endocrine System Drugs Business Overview and Total Revenue
12.3.3 Merck Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Endocrine System Drugs Products Offered
12.3.5 Merck Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Endocrine System Drugs Corporation Information
12.4.2 Eli Lilly Endocrine System Drugs Business Overview and Total Revenue
12.4.3 Eli Lilly Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly Endocrine System Drugs Products Offered
12.4.5 Eli Lilly Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Endocrine System Drugs Corporation Information
12.5.2 AstraZeneca Endocrine System Drugs Business Overview and Total Revenue
12.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Endocrine System Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 AbbVie
12.6.1 AbbVie Endocrine System Drugs Corporation Information
12.6.2 AbbVie Endocrine System Drugs Business Overview and Total Revenue
12.6.3 AbbVie Endocrine System Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AbbVie Endocrine System Drugs Products Offered
12.6.5 AbbVie Recent Development
…

13 Endocrine System Drugs Manufacturing Cost Analysis
13.1 Endocrine System Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Endocrine System Drugs
13.4 Endocrine System Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Endocrine System Drugs Distributors List
14.3 Endocrine System Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Endocrine System Drugs Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Endocrine System Drugs Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Endocrine System Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Endocrine System Drugs Sales (K Pcs) by Region (2015-2020)
Table 5. Global Endocrine System Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Endocrine System Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Endocrine System Drugs Revenue Share by Region (2015-2020)
Table 8. Global Endocrine System Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Endocrine System Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Endocrine System Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Endocrine System Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Endocrine System Drugs (K Pcs) of Key Companies (2015-2020)
Table 13. Global Endocrine System Drugs Sales Share by Company (2015-2020)
Table 14. Global Endocrine System Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Endocrine System Drugs Revenue Share by Company (2015-2020)
Table 16. Global Endocrine System Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine System Drugs as of 2019)
Table 17. Global Endocrine System Drugs Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Endocrine System Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Endocrine System Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Endocrine System Drugs Players
Table 22. Global Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 23. Global Endocrine System Drugs Sales Share by Type (2015-2020)
Table 24. Global Endocrine System Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Endocrine System Drugs Price (K Pcs) by Type (2015-2020)
Table 26. Global Endocrine System Drugs Sales Share by Type (2021-2026)
Table 27. Global Endocrine System Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Endocrine System Drugs Revenue Share by Type (2021-2026)
Table 29. Global Endocrine System Drugs Price (K Pcs) by Type (2021-2026)
Table 30. Global Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 31. Global Endocrine System Drugs Sales Share by Application (2015-2020)
Table 32. Global Endocrine System Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Endocrine System Drugs Price (K Pcs) by Application (2015-2020)
Table 34. Global Endocrine System Drugs Sales (K Pcs) by Application (2021-2026)
Table 35. Global Endocrine System Drugs Sales Share by Application (2021-2026)
Table 36. Global Endocrine System Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Endocrine System Drugs Revenue Share by Application (2021-2026)
Table 38. Global Endocrine System Drugs Price (K Pcs) by Application (2021-2026)
Table 39. United States Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 40. United States Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 42. United States Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 44. United States Endocrine System Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 51. China Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 52. China Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 53. China Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 54. China Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 55. China Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 56. China Endocrine System Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Endocrine System Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Endocrine System Drugs Sales Market Share by Application (2015-2020)
Table 69. India Endocrine System Drugs Sales (K Pcs) by Company (2015-2020)
Table 70. India Endocrine System Drugs Sales Market Share by Company (2015-2020)
Table 71. India Endocrine System Drugs Sales (K Pcs) by Type (2015-2020)
Table 72. India Endocrine System Drugs Sales Market Share by Type (2015-2020)
Table 73. India Endocrine System Drugs Sales (K Pcs) by Application (2015-2020)
Table 74. India Endocrine System Drugs Sales Market Share by Application (2015-2020)
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Novo Nordisk Endocrine System Drugs Product
Table 79. Novo Nordisk Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Sanofi Endocrine System Drugs Product
Table 84. Sanofi Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Merck Endocrine System Drugs Product
Table 89. Merck Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Eli Lilly Endocrine System Drugs Product
Table 94. Eli Lilly Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. AstraZeneca Endocrine System Drugs Product
Table 99. AstraZeneca Recent Development
Table 100. AbbVie Corporation Information
Table 101. AbbVie Description and Business Overview
Table 102. AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. AbbVie Endocrine System Drugs Product
Table 104. AbbVie Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Endocrine System Drugs Distributors List
Table 108. Endocrine System Drugs Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Endocrine System Drugs Product Picture
Figure 2. Global Endocrine System Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Endocrine System Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Medical Center Examples
Figure 9. Other Examples
Figure 10. Global Endocrine System Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Endocrine System Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Endocrine System Drugs Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Endocrine System Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Endocrine System Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Endocrine System Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Endocrine System Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Endocrine System Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Endocrine System Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Endocrine System Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Endocrine System Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Endocrine System Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Endocrine System Drugs Players Market Share by Revenue in Endocrine System Drugs 2015 & 2019
Figure 28. Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Endocrine System Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Endocrine System Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Endocrine System Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Endocrine System Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Endocrine System Drugs Sales Market Share by Type in 2019
Figure 34. United States Endocrine System Drugs Sales Market Share by Type in 2019
Figure 35. Europe Endocrine System Drugs Sales Market Share by Company in 2019
Figure 36. Europe Endocrine System Drugs Sales Market Share by Type in 2019
Figure 37. Europe Endocrine System Drugs Sales Market Share by Application in 2019
Figure 38. China Endocrine System Drugs Sales Market Share by Company in 2019
Figure 39. China Endocrine System Drugs Sales Market Share by Type in 2019
Figure 40. China Endocrine System Drugs Sales Market Share by Application in 2019
Figure 41. Japan Endocrine System Drugs Sales Market Share by Company in 2019
Figure 42. Japan Endocrine System Drugs Sales Market Share by Type in 2019
Figure 43. Japan Endocrine System Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Endocrine System Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Endocrine System Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Endocrine System Drugs Sales Market Share by Application in 2019
Figure 47. India Endocrine System Drugs Sales Market Share by Company in 2019
Figure 48. India Endocrine System Drugs Sales Market Share by Type in 2019
Figure 49. India Endocrine System Drugs Sales Market Share by Application in 2019
Figure 50. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Endocrine System Drugs
Figure 58. Manufacturing Process Analysis of Endocrine System Drugs
Figure 59. Endocrine System Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---